Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 1

1(25.0%)

Phase 4

1(25.0%)

4Total

N/A(2)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05206617Active Not Recruiting

3 Year Follow up on ANO5 Patients

Role: collaborator

NCT04614207Completed

Cerebral Palsy & Predictors of Physical Activity

Role: collaborator

NCT00915928Not ApplicableTerminated

Chronic Subdural Hematoma - Reduction of Recurrence by Treatment With Angiotensin Converting Enzyme Inhibitors

Role: collaborator

NCT01362075Not ApplicableTerminated

Pain Management After Shoulder Prosthesis: A Clinical Trial of Nerve Block and Local Infiltration

Role: collaborator

NCT01414569Phase 4Completed

Dexamethasone for Pain After Shoulder Surgery

Role: collaborator

NCT00261755Phase 1Completed

Acupuncture as Pain Relief and Relaxation During Childbirth

Role: collaborator

All 6 trials loaded